Geneva Capital Management LLC Sells 3,049 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Geneva Capital Management LLC trimmed its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 2.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 117,718 shares of the medical device company’s stock after selling 3,049 shares during the quarter. Geneva Capital Management LLC owned approximately 0.06% of Cooper Companies worth $12,989,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of COO. Vanguard Group Inc. raised its holdings in Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after acquiring an additional 17,367,502 shares during the period. Capital World Investors lifted its holdings in Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC boosted its stake in Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after purchasing an additional 2,532,186 shares during the period. Bessemer Group Inc. grew its holdings in Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after buying an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB purchased a new stake in shares of Cooper Companies in the first quarter worth about $139,246,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research analyst reports. StockNews.com upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Friday, November 8th. Piper Sandler increased their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and increased their price objective for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Finally, Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Down 1.5 %

Shares of NASDAQ COO opened at $102.00 on Wednesday. The firm’s fifty day moving average is $107.18 and its 200 day moving average is $97.82. The Cooper Companies, Inc. has a 52 week low of $81.99 and a 52 week high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The company has a market cap of $20.31 billion, a price-to-earnings ratio of 56.82, a PEG ratio of 2.23 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.84 earnings per share. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Insider Transactions at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.